An observational study of the effectiveness of darbepoetin alpha administered in dialysis patients once every 2 weeks for 12 months.

Rottembourg, J B

An observational study of the effectiveness of darbepoetin alpha administered in dialysis patients once every 2 weeks for 12 months. [electronic resource] - Clinical nephrology Mar 2011 - 242-50 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0301-0430

10.5414/cn106749 doi


Aged
Anemia--blood
Australia
Biomarkers--blood
Darbepoetin alfa
Drug Administration Schedule
Erythropoietin--administration & dosage
Europe
Female
Hematinics--administration & dosage
Hemoglobins--metabolism
Hospitalization
Humans
Longitudinal Studies
Male
Middle Aged
Peritoneal Dialysis--adverse effects
Prospective Studies
Renal Dialysis--adverse effects
Retrospective Studies
Time Factors
Treatment Outcome